Accounts Receivable are created when a customer has received a product but has not yet paid for that product. American Bio Medica's accounts receivables for the quarter that ended in Mar. 2023 was $0.09 Mil.
Accounts receivable can be measured by Days Sales Outstanding.
American Bio Medica's Days Sales Outstanding for the quarter that ended in Mar. 2023 was 49.52.
In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. American Bio Medica's Net-Net Working Capital per share for the quarter that ended in Mar. 2023 was $-0.02.
American Bio Medica Accounts Receivable Historical Data
The historical data trend for American Bio Medica's Accounts Receivable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
American Bio Medica Accounts Receivable Calculation
Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.
American Bio Medica Accounts Receivable Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.
American Bio Medica's Days Sales Outstanding for the quarter that ended in Mar. 2023 is calculated as:
2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), American Bio Medica's accounts receivable are only considered to be worth 75% of book value:
American Bio Medica's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2023 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.
If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.
Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.
American Bio Medica Accounts Receivable Related Terms
Thank you for viewing the detailed overview of American Bio Medica's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.
American Bio Medica (American Bio Medica) Business Description
American Bio Medica Corp is a us-based company engaged in manufacturing and selling lateral flow immunoassay tests, primarily for the immediate detection of certain drugs in urine and oral fluids at the point of collection. It also manufactures and sells drug testing products and provides bulk test strip manufacturing services to unaffiliated third parties on a contract basis. The company offers few urine tests which include Rapid Drug Screen, RDS InCup, Rapid TOX, and Rapid TOX Cup II. Its target customer includes workplace, government, corrections, clinical and educational markets. Geographically, it derives a majority of revenue from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ABMC has been successfully added to your 